Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Fund House: Tata Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: Nifty Pharma TRI |
| Expense Ratio: 2.65% As on (31-08-2020) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 336.53 Cr As on (30-09-2020) |
| Turn over: 56.38% | Exit Load: For units in excess of 12% of the investment,1% will be charged for redemption within 365 days |
13.5601
-0.1 (-0.7566%)
6.46%
Nifty Pharma TRI 14.23%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Current Asset Allocation (%)
Indicators
| Volatility | - |
| Sharp Ratio | - |
| Alpha | -7.87 |
| Beta | 1.61 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | 52.78 | 23.69 | 16.65 | - | - |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | 73.12 | - | - | - | - |
| Mirae Asset Healthcare Fund -Regular Growth | 05-07-2018 | 69.43 | 29.07 | - | - | - |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 01-07-2018 | 65.25 | 24.91 | - | - | - |
| UTI Healthcare Fund - Regular Plan - Growth Option | 05-08-2005 | 63.88 | 22.57 | 14.99 | 4.63 | 12.65 |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 14-07-1999 | 61.5 | 21.06 | 12.1 | 2.79 | 15.08 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | 59.38 | 21.6 | 19.48 | 7.77 | 15.2 |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | 55.02 | - | - | - | - |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | 46.05 | - | - | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
17.99%
Others
8.22%
Large Cap
51.99%
Mid Cap
21.81%
Scheme Documents
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
